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Respiratory center driveAbstract Staging criteria for COPD include symptoms and lung function parameters, but the role
of respiratory pump function parameters in determining disease severity remains unclear.
This study aimed to assess the correlation of respiratory pump functions including respiratory
center drive (P0.1), inspiratory muscle strength (PImax) and respiratory muscle fatigue
(P0.1/P0.1max%) and symptomatology in COPD patients.
This study was carried out on 80 COPD patients recruited from the outpatient clinic of Chest
Department, Tanta Faculty of Medicine. They had obstructive airﬂow limitation with
FEV1/FVC% <70% and their reversibility tests were lower than 12%. All patients were classiﬁed
according to GOLD 2015 into 4 grades (A–D).
Respiratory center drive (P0.1), respiratory muscle strength (PImax), respiratory muscle fatigue
(P0.1/P0.1max%) were assessed in all patients and correlated to COPD symptomatology.
The results of this study showed that P0.1 and P0.1/P0.1max% were signiﬁcantly higher in grade
B&D compared to grade A&C (p< 0.01) and signiﬁcantly higher in grade D compared to grade B
(p< 0.05), while PImax was signiﬁcantly lower in grade B&D compared to grade A&C (p< 0.01)
and signiﬁcantly higher in grade D compared to grade B (p< 0.05).
P0.1, PImax and P0.1/P0.1max% and resting arterial carbon dioxide tension showed a signiﬁcant
positive correlation with disease symptomatology (CAT and mMRC scales) in COPD patients
(p< 0.05) while there was an insigniﬁcant correlation between FEV1% of predicted and disease
symptoms in the studied patients.
It was concluded that, respiratory pump functions as reliably assessed by P0.1. PImax and
P0.1/P0.1max% can be considered as an important factor in rating disease severity and correlate
signiﬁcantly with symptomatology in COPD patients.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic obstructive pulmonary disease (COPD) is a chronic
disease characterized by the loss of lung elasticity and airway
narrowing resulting in airﬂow limitation [1]. This progressiverculosis.
Table 1 Patient characteristics in the four studied groups.
Age (years) Body mass index BMI
(kg/m2)
Smoking index
(pack/year)
Grade A 59.2 ± 2.3 26.2 ± 1.5 45 ± 22
Grade B 63.1 ± 1.9 25.9 ± 1.2 43 ± 20
Grade C 61.7 ± 2 25.5 ± 1.6 46 ± 23
Grade D 62.5 ± 1.8 26 ± 1.7 45 ± 21
36 G.A. Attiaairﬂow limitation leads to chronic air trapping and hyperinﬂa-
tion, especially during activity or exercise. Hyperinﬂation
causes mechanical disadvantages since it depresses the dia-
phragm and impairs intercostal muscle contractility. This
impairment increases the work and metabolic expenditure
associated with breathing and contributes to breathlessness [2].
In the diagnosis of COPD, spirometry has been used as an
objective measure to conﬁrm its symptom-based clinical
suspicion. The diagnostic criteria for COPD include a forced
expiratory volume in one second/forced vital capacity ratio
(FEV1/FVC) less than 70% of predicted value. FEV1 in
patients with COPD is used to grade the severity of airway
obstruction and as the main predictor of both disease progres-
sion and mortality [3].
Patients with COPD often exhibit respiratory muscle
weakness and reduced respiratory muscle endurance.
Respiratory muscles are submitted to multiple factors related
to both the presence and severity of COPD which may impair
their structure and function [4].
The imbalance between the respiratory muscle strength and
the load, they are chronically facing, plays an important role in
the genesis of dyspnoea and hypercapnia. It has also been
described that respiratory muscle dysfunction could be an
important determinant of increased use of health resources
and survival in hospitalized patients with severe COPD [5].
Inspiratory mouth occlusion pressure at 100 ms during
quiet breathing (P0.1) is a marker of neuromuscular ventila-
tory drive which is independent of the patient’s effort. P0.1
and the ratio of P0.1/PImax have been suggested as predictors
of impending respiratory muscle fatigue. Therefore, it may be
hypothesized that these measures also play a role for long-term
outcome in patients with COPD [6].
Patients and methods
This study was carried on 80 COPD patients recruited from
the outpatient clinic of Chest Department, Tanta Faculty of
Medicine. They had obstructive airﬂow limitation with
FEV1/FVC% <70% and their reversibility tests were lower
than 12%. All the patients were clinically stable and had been
receiving optimal medical therapy according to their group
classiﬁcation.
All the patients signed the written informed consent
approved by the ethics committee.
Patients were excluded from the study if they had:
 Past or family history suggesting asthma.
 Reversibility test higher than 12%.
 Active heart disease.
 Neuromuscular diseases.
 Disabling diseases that interfere with the tests.
All patients were classiﬁed according to GOLD 2015 [7]
criteria in 4 equal grades according to airﬂow limitation,
Symptoms & breathlessness, exacerbation history and previous
hospital admission.
The following was done for all patients:
 Post broncho-dilatation spirometric data including FVC%
of predicted, FEV1% of predicted and FEV1%.
 Functional dyspnea was assessed using:o Modiﬁed Medical Research Council Scale (mMRC)
which include 5 grades of physical activities that provoke
dyspnea and ranged from 0 (non exertional dyspnea at
all) to 4 (Breathlessness on dressing or undressing).
o COPD Assessment Test (CAT) ranging from 0 to 40.
 Number of exacerbations and hospital admission in the last
year.
 Respiratory pump function was done using ResPImax
(Andos, Hamburg, Germany Apparatus) and includes the
following:
o Respiratory center drive (P0.1): Measures the mouth
occlusion pressure after 0.1 s from initiation of inspira-
tion. Patient was asked to breathe quietly in sitting posi-
tion through the mouth piece of the apparatus ﬁtting
tightly inside the lips of the patient to prevent leakage.
The test was repeated 6 times and the mean value was
calculated.
o Respiratory muscle strength (PImax): It was measured
from residual volume at maximal inspiratory effort while
recording peak inspiratory pressures. The test was
repeated six times and the maximal value was recorded.
o Respiratory muscle fatigue: It was assessed by calculating
P0.1/P0.1max%
 Arterial blood gases: PaCO2 was measured at rest while
breathing room air using blood gas analyzer.
Results
This study was carried out on 80 COPD patients attending the
outpatient clinic of the Chest Department, Tanta Faculty of
Medicine. All of them were males. They were classiﬁed into
4 equal groups according to GOLD severity grading (A–D)
criteria.
All the patients were statistically matched as regards age,
body mass index BMI and smoking index (Table 1).
Respiratory center drive (P0.1)
One way analysis of variance in the four studied COPD grades
showed statistically signiﬁcant difference, (F= 14.32,
p< 0.05). Pairwise multiple comparisons (Tukey test) showed
that P0.1 was signiﬁcantly higher in grade B&D compared to
grade A&C (p< 0.01) and signiﬁcantly higher in grade D
compared to grade B (p< 0.05).
Respiratory muscle strength (PImax)
One way analysis of variance in the four studied COPD grades
showed statistically signiﬁcant difference, (F= 8.81,
p< 0.05). Pairwise multiple comparisons (Tukey test) showed
Figure 2 Correlation between CAT and FEV1% of predicted in
COPD patients.
Figure 3 Correlation between mMRC and FEV1% of predicted
in COPD patients.
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grade A&C (p< 0.01) and signiﬁcantly lower in grade D com-
pared to grade B (p< 0.05).
Respiratory muscle fatigue (P0.1/P0.1max%)
One way analysis of variance in the four studied COPD grades
showed statistically signiﬁcant difference, (F= 11.12,
p< 0.05). Pairwise multiple comparisons (Tukey test) showed
that P0.1/P0.1max% was signiﬁcantly higher in grade B&D
compared to grade A&C (p< 0.01) and signiﬁcantly higher
in grade D compared to grade B (p< 0.05) (Table 2).
Arterial carbon dioxide tension (PaCO2) (Fig. 1)
One way analysis of variance in the four studied COPD grades
showed statistically signiﬁcant difference, (F= 10.15,
p< 0.05). Pairwise multiple comparisons (Tukey test) showed
that PaCO2 mmHg was signiﬁcantly higher in grade B&D
compared to grade A&C (p< 0.01) and signiﬁcantly higher
in grade D compared to grade B (p< 0.05).
Correlation between FEV1% of predicted and COPD
symptomatology
In this study, there was an insigniﬁcant correlation between
FEV1% of predicted and COPD symptomatology CAT and
mMRC (r= 0.572 and 0.541 respectively, p> 0.05) (Figs. 2
and 3).
In this study, there were signiﬁcant positive correlations
between respiratory center drive function (P0.1) and COPD
symptomatology CAT and mMRC (r= 0.94 and 0.875
respectively, p< 0.05) (Figs. 4 and 5).
In this study, there were signiﬁcant negative correlations
between inspiratory muscle strength function (PImax) andTable 2 Patients classiﬁcation according to GOLD grading criteria.
FVC% of
predicted
FEV1% of
predicted
FEV1% mMRC
scale
CAT scale No. of
exacerbations
No. of hospital
admissions
Grade A 81.35 ± 1.04 81.25 ± 1.21 68.65 ± 0.75 0.35 ± 0.49 5.9 ± 0.85 0.45 ± 0.51 0
Grade B 66 ± 7.02 64.9 ± 7.81 63.8 ± 3.35 2.4±.05 23.3 ± 5.11 0.65 ± 0.49 0
Grade C 42.15 ± 4.53 40.3 ± 4.93 52.05 ± 4.11 0.7 ± 0.47 8.2 ± 0.77 2.55 ± 0.69 1.45 ± 1.51
Grade D 27.85 ± 0.93 27.6 ± 1.19 41.7 ± 2.99 3.45 ± 0.51 35.5 ± 1.82 4.35 ± 0.93 3.7 ± 0.73
Figure 1 Resting arterial carbon dioxide tension (mmHg) in the 4 COPD grades.
Figure 4 Correlation between CAT and P0.1 in COPD patients.
Figure 5 Correlation between mMRC and P0.1 in COPD
patients.
Figure 6 Correlation between CAT and PImax in COPD
patients.
Figure 7 Correlation between mMRC and PImax in COPD
patients.
Figure 8 Correlation between CAT and P0.1/P0.1max in COPD
patients.
38 G.A. AttiaCOPD symptomatology CAT and mMRC (r= 0.94 and
0.91 respectively, p< 0.05) (Figs. 6 and 7).
In this study, there were signiﬁcant positive correlations
between respiratory muscle fatigue function
(P0.1/P0.1max%) and COPD symptomatology CAT and
mMRC (r= 0.95 and 0.9 respectively, p< 0.05) (Figs. 8
and 9).
In this study, there were signiﬁcant positive correlations
between arterial carbon dioxide tension (PaCO2 mmHg) and
COPD symptomatology CAT and mMRC (r= 0.94 and
0.87 respectively, p< 0.05) (Figs. 10 and 11).
Discussion
Dyspnea is one of the leading symptoms affecting patients suf-
fering from COPD. Development of dyspnea in patients of
COPD is multifactorial and has been shown to be related to
the degree of airway obstruction, pulmonary gas exchange
abnormalities, inspiratory muscle strength, lung hyperinﬂa-
tions, respiratory central outputs and nutritional status [8]
(Table 3).
In this study, all the patients were matched as regards age,
sex and body mass index. It had been found that the degree of
airway obstruction measured by the FEV1 was insigniﬁcantlycorrelated with the CAT and mMRC score respectively. This
was consistent with a study which demonstrated that FEV1
has a poor correlation with clinical deﬁnition with COPD
and suggested that inspiratory capacity (IC) could correlate
better than FEV1 with dyspnea score and quality of life [9].
Figure 9 Correlation between mMRC and P0.1/P0.1max in
COPD patients.
Figure 10 Correlation between CAT and PaCO2 in COPD
patients.
Figure 11 Correlation between mMRC and PaCO2 in COPD
patients.
Table 3 Respiratory pump function in the 4 studied group
grading.
P0.1 (kPa) PImax (kPa) P0.1/P0.1max (%)
Grade A 0.26 ± 0.02 7.15 ± 0.24 45.85 ± 1.9
Grade B 0.37 ± 0.02a 5.19 ± .13a 57.55 ± 1.15a
Grade C 0.26 ± 0.02 6.81 ± .14 46.85 ± 1.79
Grade D 0.41 ± 0.3a,b 4.61 ± 0.19a,b 66.65 ± 2.08a,b
kPa: kilo pascal.
a Signiﬁcant compared to grade A&C.
b Signiﬁcant compared to grade B.
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COPD patients. For example, patients with mild diseases
(FEV1 higher than 80% of predicted value) or even patients
with severe or very severe diseases (less than 50% of the pre-
dicted value) show a poor correlation between FEV1 and their
clinical situation [10].Clinical experience demonstrated that patients sharing
similar FEV1 values could show different clinical parameters
as regards degree of dyspnea and show marked difference in
quality of life [11]. In COPD, hyperinﬂation or air trapping
is the result of airway obstruction and destruction of the lung
parenchyma and its vasculature. In recent years, the dynamic
hyperinﬂation in these patients has been recognized as a factor
that results in progression of dyspnea [12].
This study showed increased baseline P0.1 in all COPD
patients. This can be explained by high neural drive to
inspiratory muscle due to increased airﬂow resistance, abnor-
mal blood gas exchange, weak respiratory muscle and high
ventilatory requirements [13].
In this study, P0.1, PIMax and P0.1/P0.1max% showed
signiﬁcant correlation in all COPD patients with mMRC and
CAT score.
Respiratory muscles are submitted to multiple factors
related to both the presence and severity of COPD which
may impair their structure and function such as changes in
the chest wall geometry and diaphragm position, deleterious
shortening of the diaphragm sarcomere length, activation of
protease inspiratory muscles, oxidative stress, resting PaCO2
which were signiﬁcantly correlated with CAT and mMRC
scores [5].
A study tested whether inspiratory muscle strength is
reduced in COPD and is related to disease severity according
to GOLD (Global Initiative for Chronic Obstructive Lung
Disease) criteria and assessed its clinical impact. PImax
(maximal inspiratory mouth occlusion pressure), SnPna (sniff
nasal pressure) and TwPmo (twitch mouth pressure) following
bilateral anterior magnetic phrenic nerve stimulation were
assessed in 33 COPD patients (8 GOLD(0), 6 GOLD(I), 6
GOLD(II), 7 GOLD(III) and 6 GOLD(IV)) and in 28 matched
controls. Furthermore, all participants performed a standard-
ized 6 min walking test. In comparison with controls, PImax
(11.6 ± 2.5 compared with 7.3 ± 3.0 kPa; p< 0.001), SnPna
(9.7 ± 2.5 compared with 6.9 ± 3.3 kPa; p< 0.001) and
TwPmo (1.6 ± 0.6 compared with 0.8 ± 0.4 kPa; p< 0.001)
were markedly lower in COPD patients. TwPmo decreased
with increasing COPD stage. TwPmo was correlated with walk-
ing distance (r= 0.75; p< 0.001), dyspnoea (r= 0.61;
p< 0.001) and blood gas values following exercise (r> 0.57;
p< 0.001). Inspiratory muscle strength, as reliably assessed
by TwPmo, decreased with increasing severity of COPD and
should be considered as an important factor in rating disease
severity and to reﬂect burden in COPD [14].
In this study, hypercapnia correlated signiﬁcantly with
symptomatology in all COPD patients.
40 G.A. AttiaChronic hypercapnic respiratory failure pathophysiologi-
cally, results from disturbances in the respiratory pump by
mechanical disadvantage, central nervous system abnormali-
ties or respiratory muscle dysfunction. Chronic hypercapnia
is commonly considered an ominous prognostic sign, but the
corresponding hypoventilation could also be favorable in pre-
venting respiratory muscle fatigue [15].
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